Polydimethylsiloxane (macroplastique®) injection for vesicoureteral reflux in duplex ureters: a comparison with single renal systems

J Pediatr Urol. 2011 Oct;7(5):516-9. doi: 10.1016/j.jpurol.2010.09.002. Epub 2010 Oct 5.

Abstract

Objective: VUR in patients with a duplex system (DS) is often treated by open surgery. The aim of this study was to evaluate the efficacy of subureteric polydimethylsiloxane (Macroplastique(®)) injection (SMING) in the management of VUR in duplex and single (SS) renal systems.

Patients and methods: Fifteen children (24 refluxing renal units) with VUR in DS underwent SMING. VUR was more frequent in the lower moiety. VUR was graded moderate/severe in 88% of renal units. There was a history of urinary tract infections in 40% of cases. The outcome for DS patients was compared with 44 children (60 refluxing renal units) with moderate/severe VUR in SS.

Results: The VUR resolution/improvement rate was 88% in DS and 95% in SS patients. Ureteric reimplantation was required because of recurrent VUR in 13% and 7% of DS and SS groups, respectively. Transient ureteral obstruction was observed in 1/15 and 5/44 patients. Two required double-J ureteric stenting for 3 months.

Conclusion: SMING seems an effective treatment for VUR in both DS and SS patients, even in severe cases. The complication rate does not significantly differ between the two groups.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Dimethylpolysiloxanes / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections
  • Male
  • Time Factors
  • Treatment Outcome
  • Ureter / abnormalities*
  • Ureter / surgery
  • Urodynamics
  • Vesico-Ureteral Reflux / congenital
  • Vesico-Ureteral Reflux / physiopathology
  • Vesico-Ureteral Reflux / surgery*

Substances

  • Dimethylpolysiloxanes
  • baysilon